GLP-1 (S) Semaglutide (5mg)

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the GLP-1 hormone, released in the gut in response to eating. GLP-1 promotes insulin release, which reduces blood sugar. It also slows gastric emptying and promotes satiety, making it a key compound in metabolic research. It is classified under the Metabolic Peptides research category and is studied in the following areas: Metabolic Health, Blood Sugar Regulation, Appetite, Weight Management.

Our GLP-1 (S) Semaglutide (5mg) is tested at 99%+ purity via third-party HPLC analysis. Every order ships with a Certificate of Analysis (COA) documenting purity, identity, and endotoxin levels.

GLP-1 (S) Semaglutide (5mg) should be stored at -20°C. It is supplied as a lyophilized powder and is soluble in bacteriostatic water.

GLP-1 receptor agonist; enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and promotes satiety via hypothalamic signaling

GLP-1 (S) Semaglutide (5mg) has a molecular weight of 4113.58 g/mol. Its amino acid sequence is: His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly.

Yes. Every batch of GLP-1 (S) Semaglutide (5mg) is third-party tested and ships with a full Certificate of Analysis (COA) documenting HPLC purity, mass spectrometry identity confirmation, and endotoxin testing results.

~7 days (due to albumin binding and DPP-4 resistance)

In published research, GLP-1 (S) Semaglutide (5mg) has been administered via subcutaneous injection, oral administration. All use is for laboratory research purposes only.